Cap table modeling, ESOP structuring, CCPS/CCD issuance, and anti-dilution protection — ensuring you retain control while raising capital efficiently.
Every funding round dilutes the founders' stake. Without careful modeling, founders can lose control, trigger anti-dilution clauses, or create misaligned incentive structures. Equity dilution advisory ensures optimal cap table management through every funding stage.
A poorly structured funding round can leave founders with less than 20% equity by Series C, destroy employee morale through ESOP dilution, or create complex liquidation preferences that wipe out common shareholders on exit.
SilverSiX models every scenario — from seed to IPO — ensuring you understand the impact of each term sheet clause before you sign.
Dynamic cap table modeling across multiple funding scenarios, exit valuations, and instrument types.
Design and implementation of employee stock option plans that attract talent without excessive founder dilution.
Selection and design of optimal securities for each funding round — equity, CCPS, CCD, or convertible notes.
Structuring anti-dilution protections that balance investor security with founder equity preservation.
Designing exit waterfalls that protect investor downside while preserving founder upside.
Advisory on term sheet clauses from a founder-control and dilution-minimization perspective.
Comprehensive review of existing cap table, shareholder agreements, and instrument terms.
Building round-by-round dilution models for seed, Series A, B, C, and exit scenarios.
Clause-by-clause analysis of investor term sheets with dilution impact quantification.
Recommending optimal securities and structuring terms to minimize founder dilution.
SHA, SPA, and ESOP plan drafting with regulatory compliance (Companies Act, FEMA, SEBI).
Cap table updates, ESOP grant tracking, and pre-funding dilution checks.
| Deliverable | Description | Timeline |
|---|---|---|
| Cap Table Model | Excel model with all scenarios & waterfalls | Week 1 |
| Dilution Impact Note | Founder stake % across rounds & exit | Week 2 |
| Term Sheet Review | Red-line comments with dilution quantification | Week 2 |
| Instrument Memo | CCPS vs. CCD vs. equity recommendation | Week 3 |
| ESOP Plan Draft | Companies Act compliant ESOP scheme | Week 3 |
| SHA Compliance Note | FEMA + SEBI compliance check on draft SHA | Week 4 |
| Liquidation Waterfall | Exit proceeds distribution by class | Week 4 |
| Board Presentation | Investor-ready cap table & dilution summary | Week 5 |
Book a confidential discovery call with our advisory team. We assess your situation and outline a clear execution roadmap within 48 hours.
Schedule a Consultation →